Perspective Therapeutics (CATX) EBITDA Margin (2010 - 2023)
Perspective Therapeutics (CATX) recorded EBITDA Margin of -2783.47% in FY2023.
Powered by 
Analysis
Perspective Therapeutics (CATX) EBITDA Margin (2010 - 2023) Analysis & Trends
Starting with FY2011, Perspective Therapeutics' EBITDA Margin history includes 13 years.
- Annual EBITDA Margin has a five-year change of -2672.06 percentage points (FY2018 to FY2023).
- The FY2023 figure is the lowest annual EBITDA Margin in data going back to FY2011.
- Per Business Quant data, CATX's EBITDA Margin was -57.70% in FY2022 (-25.27 pp), -32.43% in FY2021 (+1.57 pp), -34.00% in FY2020 (+35.29 pp) and -69.29% in FY2019 (+42.12 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Perspective Therapeutics | 298.91 Mn | 298.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -433.91% |
| Jun 30, 2023 | -454.45% |
| Mar 31, 2023 | -463.45% |
| Sep 30, 2022 | -240.83% |
| Jun 30, 2022 | -81.08% |
| Mar 31, 2022 | -44.40% |
| Dec 31, 2021 | -55.40% |
| Sep 30, 2021 | -86.00% |
| Jun 30, 2021 | -38.45% |
| Mar 31, 2021 | -27.73% |
| Dec 31, 2020 | -35.06% |
| Sep 30, 2020 | -28.10% |
| Jun 30, 2020 | -50.29% |
| Mar 31, 2020 | -17.47% |
| Dec 31, 2019 | -38.76% |
| Sep 30, 2019 | -34.00% |
| Jun 30, 2019 | -56.91% |
| Mar 31, 2019 | -58.00% |
| Dec 31, 2018 | -72.64% |
| Sep 30, 2018 | -94.37% |
API Access
Perspective Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();